Abstract
The main aim of this paper is to investigate the impact of liquidity on the profitability of pharmaceutical companies listed on Bombay Stock Exchange (BSE). Data are extracted from ProwessIQ database. The analysis is done using a balanced panel data of 82 pharmaceutical companies for the period of 10 years from 2008 to 2017. Findings reveal that current liquidity ratio and quick ratio have a positive and significant impact on the profitability of pharmaceutical companies measured by return on assets, while control variables leverage, firms’ size, and age have a negative impact on the profitability of pharmaceutical companies. The study used recent literature to explore the gap in the existing literature. This study will be useful for regulators, finance managers and other people concerned about liquidity in order to understand its importance. This study is considered one of the pioneering studies that examines the impact of liquidity in the financial performance of Indian pharmaceutical companies. It is considered a battery for further research in this area.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
